| Target Price | $98.94 |
| Price | $95.16 |
| Potential |
3.97%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Merus N.V. 2026 .
The average Merus N.V. target price is $98.94.
This is
3.97%
register free of charge
$115.50
21.37%
register free of charge
$92.92
2.35%
register free of charge
|
|
| A rating was issued by 23 analysts: 9 Analysts recommend Merus N.V. to buy, 14 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Merus N.V. stock has an average upside potential 2026 of
3.97%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 36.13 | 55.22 |
| 17.79% | 52.83% | |
| EBITDA Margin | -746.19% | -700.44% |
| 112.94% | 6.13% | |
| Net Margin | -595.99% | -809.21% |
| 69.06% | 35.78% |
22 Analysts have issued a sales forecast Merus N.V. 2025 . The average Merus N.V. sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Merus N.V. EBITDA forecast 2025. The average Merus N.V. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Merus N.V. Analysts have issued a net profit forecast 2025. The average Merus N.V. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.35 | -5.91 |
| 11.67% | 76.42% | |
| P/E | negative | |
| EV/Sales | 117.85 |
20 Analysts have issued a Merus N.V. forecast for earnings per share. The average Merus N.V. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Leerink Partners |
Locked
➜
Locked
|
Locked | Oct 06 2025 |
| LifeSci Capital |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Oct 06 2025 |
|
Locked
LifeSci Capital:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


